Al Kim, MD, PhD, launched the COVaRiPAD study, a multi-departmental effort (Medicine, Neurology, Molecular Microbiology, Pathology & Immunology, Genetics) to examine COVID-19 vaccine responses in patients with autoimmune diseases
Al Kim, MD, PhD, launched the COVaRiPAD study
![](https://rheumatology.wustl.edu/wp-content/uploads/2021/01/Al-Kim-WUSTL-1024x678.jpg)